Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Priya Singhal

At a glance: Priya Singhal is Head Of Development at Biogen (BIIB). Their latest SEC Form 4, filed Feb 10, 2026, reported a sale of $532K. On file: 0 purchase lines ($0) and 2 sale lines ($666K).

Disclosed holdings: about $2.0M of BIIB stock: 8,043 shares reported on their latest Form 4 (filed Feb 10, 2026), valued at the Nov 20, 2026 close of $249.69. This counts only BIIB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Head Of Development at Biogen Inc. (BIIB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $666K

Priya Singhal's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Priya Singhal: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 10SEC BIIBBiogen Inc. Sell Plan 2,6608,043 held (−25%) $199.83 $532K +25.0%
Feb 3SEC BIIBBiogen Inc. Sell Plan 7486,271 held (−11%) $179.30 $134K +39.3%
  • Sell

    Head Of Development Priya Singhal sold $532K of BIIB at $199.83 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Head Of Development Priya Singhal sold $134K of BIIB at $179.30 — pre-scheduled 10b5-1 plan sale.

Follow Priya Singhal

Get one email when Priya Singhal files a new purchase or sale. Free.

At most one email a day about Priya Singhal, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.